Advertisements

Esperion Therapeutics Inc. (ESPR) Stock Quote

Detailed Quote for Esperion Therapeutics Inc. (ESPR)
$ 49.37   -0.30 (-0.60%) Volume: 233.17k 4:00 PM EDT Sep 21, 2017
After Hours:  $ 49.37 0.00 (0.00%) Volume: 6.54k 4:52 PM EDT Sep 21, 2017
Today 5d 1m 3m 1y more
Last Price
49.37
Change $
0.30
Change %
0.60%
Tick
  
Bid
47.50
Bid Size
200
Ask
51.70
Ask Size
100
Open
49.76
High
49.825
Low
48.849
Prev Close
49.67
Last Trade
09/21/17
Volume
233.17k
52 Wk Hi
57.380001
52 Wk Low
9.39999961
Market Cap
1.12b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
22,593,162
EPS (TTM)
-5.7800002
PE Ratio
N/A
Exchange
NSD
News and Media for Esperion Therapeutics Inc. (ESPR)
Sector News | Topic News
News for Esperion Therapeutics Inc. (ESPR)
Thu, Sep 21, 2017
8:35 PM Esperion Therapeutics Remains Undervalued - SeekingAlpha
Tue, Sep 19, 2017
7:28 AM Will The Federal Reserve Send The Market Higher? - SeekingAlpha
Thu, Sep 07, 2017
2:51 PM Biotech Bonanza: A Key Piece Falls In Place - SeekingAlpha
Thu, Aug 24, 2017
10:42 AM Esperion Therapeutics: Does The Rally 'Have Legs'? - SeekingAlpha
Sat, Aug 19, 2017
6:22 AM Week 34 Breakout Forecast: Short-Term Picks To Give You An Edge - SeekingAlpha
Fri, Aug 11, 2017
4:30 PM Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
9:00 AM 3 Things In Biotech You Should Learn Today: August 11, 2017 - SeekingAlpha
Thu, Aug 10, 2017
6:56 AM Esperion prices stock offering at $49; shares off 1% premarket - SeekingAlpha
Wed, Aug 09, 2017
9:20 PM Esperion Prices Public Offering of Common Stock - GlobeNewswire
3:39 PM Esperion's Triple Combo Hits A Home Run - SeekingAlpha
2:01 PM Positive Triplet Data Should Accelerate Esperion Deal-Making Chatter - SeekingAlpha
8:11 AM Today's Research Reports on Stocks to Watch: Esperion Therapeutics and Valeant Pharmaceuticals - ACCESSWIRE IA
7:25 AM Premarket analyst action - healthcare - SeekingAlpha
Tue, Aug 08, 2017
10:27 PM Esperion Therapeutics' (ESPR) CEO Tim Mayleben on Q2 2017 Results - Earnings Call Transcript - SeekingAlpha
4:43 PM Esperion Therapeutics misses by $0.30 - SeekingAlpha
4:31 PM Esperion Announces Proposed Public Offering of Common Stock - GlobeNewswire
12:53 PM Midday Gainers / Losers - SeekingAlpha
9:23 AM Premarket Gainers as of 9:05 am - SeekingAlpha
8:48 AM Esperion's bempedoic acid successful in mid-stage study; shares ahead 16% premarket - SeekingAlpha
8:00 AM Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2017 Financial Results - GlobeNewswire
More News for ESPR >>

Tags for Esperion Therapeutics Inc.

Research stocks or mutual funds related to Esperion Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ESPR. The keywords below have been associated to ESPR by either user submission or electronic means.